You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. COMPASS PATHWAYS PLC - ADR

Compass Pathways Plc - ADR XNAS: CMPS

Compass Pathways Plc - ADR Live Share Price Today, Share Analysis and Chart

Download real time

3.46 -0.02 (-0.57%)

66.44% Fall from 52W High

572.4K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The board meeting for Compass Pathways Plc - ADR is scheduled for today, for the purpose of Stifel Virtual CNS Forum See details

Compass Pathways Plc - ADR Key Metrics

Default

Market Capitalization

Below industry Median
320.6

PE TTM

Negative PE TTM
-2.1

PEG TTM

Below industry Median
0.1

Price to Book

Below industry Median
2.1

Institutional holding current Qtr %

Below industry Median
33.6

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-33.2

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-30.9

Piotroski Score

Below industry Median
1

Rel Perf vs Sector quarter%

-24

ROE Annual %

Negative ROE Annual %
-81.5

RoA Annual %

Negative RoA Annual %
-63.4
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
7.3 / 100
Momentum Score
Technically Bearish
24.1 / 100
Analyst Price Target
No estimates available

5

S

19

W

2

O

1

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Compass Pathways Plc - ADR Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Compass Pathways Plc - ADR Stock Analysis

Compass Pathways Plc - ADR stock analysis with key metrics, changes, and trends.

Compass Pathways Plc - ADR MetricVALUECHANGE %TRENDANALYSIS
Annual Net Profit$155.12 M30.94%negative

Annual Net Profit fell 30.94% in the last year to $155.12 M. Its sector's average net profit growth for the last fiscal year was -32.47%.

Price to Earning Ratio-2.07-negative

Price to Earning Ratio is -2.07, which is negative.

Stock Price$3.46-65.05%negative

Stock Price fell 65.05% and underperformed its sector by 74.41% in the past year.

Quarterly Net profit$43.33 M33.2%negative

Quarterly Net profit fell 33.2% YoY to $43.33 M. Its sector's average net profit growth YoY for the quarter was -47.43%.

Debt to Equity Ratio0.21-positive

Debt to Equity Ratio of 0.21 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-81.55 %-81.55%negative

Return on Equity(ROE) for the last financial year was -81.55%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding5.51 %-0.53%negative

Mutual Fund Holding decreased by 0.53% in the last quarter to 5.51.

Interest Coverage Ratio-33.28-negative

Interest Coverage Ratio is -33.28, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding33.57 %0%neutral

Institutional Holding remained the same in the last quarter at 33.57%.

VIEW LESS


Loading data..

Compass Pathways Plc - ADR - Company Profile

What does Compass Pathways Plc - ADR do?

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

Compass Pathways Plc - ADR Management structure

All Gross Remunerations are in USD
Ms. Lori Englebert
Chief Commercial Officer
-
2024
Gross Remuneration
Year
Mr. Kabir Nath
Director and Chief Executive Officer
-
2024
Gross Remuneration
Year
Ms. Teri Loxam
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Compass Pathways Plc - ADR Board of directors

All Gross Remunerations are in USD
Mr. Gino Santini
Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. David York Norton
Lead Independent Director
-
2024
Gross Remuneration
Year
Mr. George Goldsmith
Chairman of the Board
-
2024
Gross Remuneration
Year
Dr. Ekaterina Malievskaia, M.D.
Director
-
2024
Gross Remuneration
Year
Dr. Wayne Joseph Riley, M.B.A.,M.D.,M.P.H.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Kabir Nath
Director and Chief Executive Officer
-
2024
Gross Remuneration
Year

Compass Pathways Plc - ADR FAQ

How is Compass Pathways Plc - ADR today?
Compass Pathways Plc - ADR today is trading in the red, and is down by -0.57% at 3.46.
Compass Pathways Plc - ADR is currently trading down -0.57% on an intraday basis. In the past week the stock fell -2.26%. stock has been down -17.62% in the past quarter and fell -65.05% in the past year. You can view this in the overview section.